ELSA NEGRIN: Open Payments
NPI 1689943706 · EAST WINDSOR, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,351 in 54 payments from 15 companies in 2025. Trend: 2023 $1,839 · 2024 $2,524 · 2025 $2,351
Food & beverage: $2,351
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $721 |
| Axsome Therapeutics, Inc. | 6 | $405 |
| Phathom Pharmaceuticals, Inc. | 4 | $270 |
| ABBVIE INC. | 13 | $256 |
| SANOFI-AVENTIS U.S. LLC | 3 | $156 |
| Lundbeck LLC | 2 | $120 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $105 |
| Exact Sciences Corporation | 4 | $104 |
| Amgen Inc. | 4 | $69 |
| Novo Nordisk Inc | 3 | $47 |
Products named: Auvelity, VOQUEZNA, BREZTRI, VRAYLAR, AIRSUPRA, TZIELD, FARXIGA, FASENRA.
Industry payments across NJ — which companies pay providers there.
